Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Selecta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Selecta Biosciences Raises USD38 Million in Series E Financing 12
Selecta Bioscience Raises USD6 Million in Venture Financing 14
Selecta Biosciences Raises More than USD20 Million in Venture Financing 15
Selecta Biosciences Raises USD4.4 Million in Venture Financing 17
Selecta Biosciences Raises USD6 Million in Venture Financing 18
Selecta Biosciences Raises USD5.3 Million in Venture Financing 19
Private Equity 20
Reinet Investments Invests USD4.43 Million in Selecta Biosciences 20
Partnerships 21
Selecta Biosciences Enters into Research Agreement with Genethon 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Licensing Agreements 23
Selecta Biosciences Enters into Licensing Agreement with National Cancer Institute 23
Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences 25
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 27
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 28
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 29
Equity Offering 30
Selecta Biosciences Files Registration Statement to Raise Funds through Public Offering of Shares 30
Selecta Biosciences Raises USD50 Million in Private Placement of Shares and Warrants 31
Selecta Biosciences to Raise USD5 Million in Private Placement of Shares 32
Selecta Biosciences Raises USD70 Million in IPO 34
Selecta Biosciences Inc – Key Competitors 36
Selecta Biosciences Inc – Key Employees 37
Selecta Biosciences Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 08, 2018: Selecta Biosciences announces second quarter 2018 financial results and provides corporate update 39
May 09, 2018: Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update 41
Mar 15, 2018: Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update 42
Nov 07, 2017: Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate Update 44
Aug 11, 2017: Selecta Biosciences Announces Second Quarter 2017 Financial Results and Provides Corporate Update 46
May 11, 2017: Selecta Biosciences Announces First Quarter 2017 Financial Results and Provides Corporate Update 48
Mar 27, 2017: Selecta Biosciences Announces Fourth Quarter and Year End 2016 Financial Results and Provides Corporate Update 50
Corporate Communications 53
Sep 27, 2018: Selecta Biosciences names Carsten Brunn, Ph.D. as President and Chief Executive Officer 53
Jan 02, 2018: Massachusetts Selecta Biosciences’ CEO to Retire at the End of 2018 54
Jan 02, 2018: Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan 55
Oct 26, 2017: Selecta Biosciences Announces Important Additions to Senior Leadership Team 56
Product News 57
05/01/2017: Selecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy 57
Clinical Trials 58
Mar 12, 2018: Selecta Biosciences Announces First Patient Dosed in Phase 1 Trial of SVP-Rapamycin and LMB-100 Combination Therapy in Mesothelioma 58
Jan 09, 2018: Publication Authored by Researchers at Selecta Biosciences and the National Cancer Institute in Proceedings of the National Academy of Sciences (PNAS) Discusses Restoration of Anti-Tumor Activity of Recombinant Immunotoxin LMB-100 When Combined with SVP-R 59
Jan 02, 2018: Selecta Biosciences Announces FDA Acceptance of Investigational New Drug Application for LMB-100 and SVP-Rapamycin Combination Therapy 60
May 15, 2017: Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy 61
May 11, 2017: Selecta Biosciences Commences Dosing in Phase 1 Clinical Trial of Nicotine Vaccine for Smoking Cessation and Relapse Prevention 62
Feb 06, 2017: Selecta Biosciences Presents Preclinical Data Regarding SVP-Enabled Celiac Disease Treatment 63
Feb 06, 2017: Selecta Biosciences Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Selecta Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Selecta Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Selecta Biosciences Raises USD38 Million in Series E Financing 12
Selecta Bioscience Raises USD6 Million in Venture Financing 14
Selecta Biosciences Raises More than USD20 Million in Venture Financing 15
Selecta Biosciences Raises USD4.4 Million in Venture Financing 17
Selecta Biosciences Raises USD6 Million in Venture Financing 18
Selecta Biosciences Raises USD5.3 Million in Venture Financing 19
Reinet Investments Invests USD4.43 Million in Selecta Biosciences 20
Selecta Biosciences Enters into Research Agreement with Genethon 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Selecta Biosciences Enters into Licensing Agreement with National Cancer Institute 23
Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences 25
Selecta Biosciences Enters into Licensing Agreement with Massachusetts Eye and Ear Infirmary 27
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 28
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 29
Selecta Biosciences Files Registration Statement to Raise Funds through Public Offering of Shares 30
Selecta Biosciences Raises USD50 Million in Private Placement of Shares and Warrants 31
Selecta Biosciences to Raise USD5 Million in Private Placement of Shares 32
Selecta Biosciences Raises USD70 Million in IPO 34
Selecta Biosciences Inc, Key Competitors 36
Selecta Biosciences Inc, Key Employees 37
Selecta Biosciences Inc, Subsidiaries 38
List of Figures
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Selecta Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9